The Clinical Genomics Market is expected to reach USD 879.0 million by 2023, at a CAGR of 17.1% during the forecast period of 2018 to 2023. With the comprehensive secondary and primary research on clinical genomics tests and software and an in-depth analysis of the market scenario, the report carries out an impact analysis of the key industry drivers, restraints, opportunities, challenges, and trends in the global market. The global clinical genomics market is mainly driven by growing significance of early disease detection and prevention, rising insistence for precision medicine, increasing application of genetic testing in oncology, and favourable reimbursement scenario related to genetic testing. However, high cost and social and ethical implications of genetic testing hinder the growth of clinical genomics market to some extent.
Click here to : Get Free Sample Pages of this Report
Market Segmentation
The global clinical genomics market is mainly segmented by test type (diagnostic testing, genetic testing, newborn screening, prenatal testing, preimplantation testing, carrier screening and other tests), software, method (molecular tests, chromosomal tests, biochemical tests), end user (hospitals & clinics, government laboratories & research centers, academics and research institutes and other end users), and geography (North America, Europe, Asia-Pacific, and Rest of World).
Geographic Overview
Geographically, the global clinical genomics market is segmented into four major regions, namely North America, Europe, Asia-Pacific, and Rest of World. North America accounted for the major share in the global clinical genomics market in 2017, followed by Europe, and Asia-Pacific. The major share of the North American region is mainly attributed to the public awareness regarding genetic testing, high burden of inherited and rare disorders, increasing R&D expenditure, and various government initiatives. On the other hand, Asia-Pacific region is projected to grow at the fastest CAGR during the forecast period, mainly due to increasing population, rising rate of diseases, and various government initiatives for the genomic research in order to understand the complex biological process and genetic mutation present in life-threatening diseases.
The geographical analysis provides detailed insights on the key trends of the industry in the listed regions, identifying the demographic & economic impact, government & private investments, market opportunities and forecast, and regulatory scenario. The geographical analysis section also comments on the key market players shaping the growth of the industry in the respective regions, market size, and forecast for clinical genomics market till 2023.
Key players
The report includes the competitive landscape based on extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past 4 years. The study has also incorporated the detailed profiles of 25 top market players, including detailed financial performance, strategic focus, business overviews, and product offerings of each player. The key players in the global clinical genomics marketare Quest Diagnostics Incorporated (U.S.), Eurofins Scientific SE (Luxembourg), Illumina, Inc. (U.S.), PerkinElmer, Inc. (U.S.), NeoGenomics Inc. (U.S.), Foundation Medicine, Inc. (U.S.), Rosetta Genomics Ltd. (Israel), Invitae Corporation (U.S.), Myriad Genetics, Inc. (U.S.), Natera, Inc. (U.S.), Genomic Health, Inc. (U.S.), OPKO Health, Inc. (U.S.), Centogene AG (Germany), Clinical Genomics Pty Ltd. (Australia), 23andMe, Inc. (U.S.), Iverson Genetic Diagnostics, Inc. (U.S.), Veritas Genetics (U.S.), Gene by Gene, Ltd. (U.S.), GenomeDx Biosciences, Inc. (Canada), MedGenome (India), Strand Life Sciences Pvt. Ltd. (India), Beijing Genomics Institute (BGI) (China), Retrogen, Inc. (U.S.), Personalis, Inc. (U.S.), and PathGroup (U.S.).
Scope of the Report:
Clinical Genomics Market by Test Type:
Clinical Genomics Market by Method:
Clinical Genomics Market by End User:
Clinical Genomics Market by Geography:
Key questions answered in the report:
Adoption of test over software will propel the clinical genomics market
Hospitals & clinics end user accounted for the largest share of the clinical genomics market
The Asia-Pacific clinical genomics market favors both larger and local manufacturers that compete in multiple segments
We are in the phase of updating this report by analysing the impact of COVID-19 on this market.
1. Introduction
1.1. Currency and Limitations
1.1.1. Currency
1.1.2. Limitations
2. Research Methodology
2.1. Research Process
2.1.1. Secondary Research
2.1.2. Primary Research
2.1.3. Market Size Estimation
3. Executive Summary
4. Market Share Analysis
5. Market Insights
5.1. Introduction
5.1.1. Drivers
5.1.1.1. Growing Significance of Early Disease Detection and Prevention
5.1.1.2. Rising Insistence for Precision Medicine
5.1.1.3. Increasing Application of Genetic Testing in Oncology
5.1.1.4. Favorable Reimbursement Scenario Related to Genetic Testing
5.1.2. Restraints
5.1.2.1. Enormous Cost of Genetic Testing
5.1.2.2. Social and Ethical Implications of Genetic Testing
5.1.3. Opportunities
5.1.3.1. Genetic Counseling
5.1.3.2. Genetic Nursing
5.1.4. Challenges
5.1.4.1. Accuracy & Standardization Concerns in Genetic Testing
5.1.5. Trends
5.1.5.1. Growing Direct to Consumer Genetic Testing
6. Clinical Genomics Market, by Product/Service Type
6.1. Introduction
6.2. Tests
6.3. Software
7. Clinical Genomics Market, by Test Type
7.1. Introduction
7.2. Diagnostic Testing
7.3. Genetic Testing
7.4. Newborn Screening
7.5. Prenatal Testing
7.6. Preimplantation Testing
7.7. Carrier Testing
7.8. Other Tests
8. Clinical Genomics Market, by Method
8.1. Introduction
8.2. Molecular Tests
8.3. Chromosomal Tests
8.4. Biochemical Tests
9. Clinical Genomics Market, by End User
9.1. Introduction
9.2. Hospitals & Clinics
9.3. Government Laboratories & Research Centers
9.4. Academic & Research Institutes
9.5. Other End-Users
10. Clinical Genomics Market, by Geography
10.1. Introduction
10.2. North America
10.2.1. U.S.
10.2.2. Canada
10.3. Europe
10.4. Asia Pacific
10.5. Rest of the World (RoW)
11. Competitive Landscape
11.1. Introduction
11.2. Agreements, Collaborations, and Partnerships
11.3. New Product Launches & Enhancements
11.4. Expansions
11.5. Mergers & Acquisitions
11.6. Approvals
11.7. Other Developments
12. Company Profiles (Business Overview, Financial Overview, Product Portfolio, Recent Strategic Developments)
12.1. Quest Diagnostics Incorporated
12.2. Eurofins Scientific SE
12.3. Illumina, Inc.
12.4. PerkinElmer, Inc.
12.5. NeoGenomics, Inc.
12.6. Foundation Medicine, Inc.
12.7. Rosetta Genomics, Ltd.
12.8. Invitae Corporation
12.9. Myriad Genetics, Inc.
12.10. Natera, Inc.
12.11. Genomic Health, Inc.
12.12. OPKO Health, Inc.
12.13. CENTOGENE AG
12.14. Clinical Genomics Technologies Pty Ltd.
12.15. 23andMe, Inc.
12.16. Iverson Genetic Diagnostics, Inc.
12.17. Veritas Genetics
12.18. Gene by Gene Ltd
12.19. GenomeDx Biosciences, Inc.
12.20. MedGenome
12.21. Strand Life Sciences Pvt. Ltd.
12.22. Beijing Genomics Institute (BGI)
12.23. Retrogen, Inc.
12.24. Personalis, Inc.
12.25. Pathgroup
13. Appendix
13.1. Questionnaire
13.2. Available Customization
List of Tables
Table 1 Global Clinical Genomics Market Size, by Type, 2016-2023 (USD Million)
Table 2 Global Clinical Genomics Tests Market Size, by Region/Country, 2016-2023 (USD Million)
Table 3 Global Clinical Genomics Software Market Size, by Region/Country, 2016-2023 (USD Million)
Table 4 Global Clinical Genomics Market Size, by Test Type, 2016-2023 (USD Million)
Table 5 Global Clinical Genomics Diagnostic Testing Market Size, by Region/Country, 2016-2023 (USD Million)
Table 6 Global Clinical Genomics Genetic Testing Market Size, by Region/Country, 2016-2023 (USD Million)
Table 7 Global Clinical Genomics Newborn Screening Market Size, by Region/Country, 2016-2023 (USD Million)
Table 8 Global Clinical Genomics Prenatal Testing Market Size, by Region/Country, 2016-2023 (USD Million)
Table 9 Global Clinical Genomics Preimplantation Testing Market Size, by Region/Country, 2016-2023 (USD Million)
Table 10 Global Clinical Genomics Carrier Screening Market Size, by Region/Country, 2016-2023 (USD Million)
Table 11 Global Clinical Genomics Other Tests Market Size, by Region/Country, 2016-2023 (USD Million)
Table 12 Global Clinical Genomics Market Size, by Method, 2016-2023 (USD Million)
Table 13 Global Clinical Genomics Market Size for Molecular Tests, by Region/Country, 2016-2023 (USD Million)
Table 14 Global Clinical Genomics Market Size for Chromosomal Tests, by Region/Country, 2016-2023 (USD Million)
Table 15 Global Clinical Genomics Market Size for Biochemical Tests, by Region/Country, 2016-2023 (USD Million)
Table 16 Global Clinical Genomics Market Size, by End-User, 2016-2023 (USD Million)
Table 17 Global Clinical Genomics Market Size for Hospitals and Clinics, by Region/Country, 2016-2023 (USD Million)
Table 18 Global Clinical Genomics Market Size for Government Laboratories & Research Centres, by Region/Country, 2016-2023 (USD Million)
Table 19 Global Clinical Genomics Market Size for Academics and Research Institutes, by Region/Country, 2016-2023 (USD Million)
Table 20 Global Clinical Genomics Market Size for other End-Users, by Region/Country, 2016-2023 (USD Million)
Table 21 Global Clinical Genomics Market Size, by Region/Country, 2018-2023 (USD Million)
Table 22 North America: Clinical Genomics Market Size, by Country, 2016-2023 (USD Million)
Table 23 North America: Market Size, by Services, 2016-2023 (USD Million)
Table 24 North America: Market Size, by Test Type, 2016-2023 (USD Million)
Table 25 North America: Market Size, by Method, 2016-2023 (USD Million)
Table 26 North America: Market Size, by End-User, 2016-2023 (USD Million)
Table 27 U.S.: Clinical Genomics Market Size, by Services, 2016-2023 (USD Million)
Table 28 U.S.: Market Size, by Test Type, 2016-2023 (USD Million)
Table 29 U.S.: Market Size, by Method, 2016-2023 (USD Million)
Table 30 U.S.: Market Size, by End-User, 2016-2023 (USD Million)
Table 31 Canada: Clinical Genomics Market Size, by Services, 2016-2023 (USD Million)
Table 32 Canada: Market Size, by Test Type, 2016-2023 (USD Million)
Table 33 Canada: Market Size, by Method, 2016-2023 (USD Million)
Table 34 Canada: Market Size, by End-User, 2016-2023 (USD Million)
Table 35 Europe: Clinical Genomics Market Size, by Services, 2016-2023 (USD Million)
Table 36 Europe: Market Size, by Test Type, 2016-2023 (USD Million)
Table 37 Europe: Market Size, by Method, 2016-2023 (USD Million)
Table 38 Europe: Market Size, by End-User, 2016-2023 (USD Million)
Table 39 APAC: Clinical Genomics Market Size, by Services, 2016-2023 (USD Million)
Table 40 APAC: Clinical Genomics Market Size, by Test Type, 2016-2023 (USD Million)
Table 41 APAC: Clinical Genomics Market Size, by Method, 2016-2023 (USD Million)
Table 42 APAC: Clinical Genomics Market Size, by End -User, 2016-2023 (USD Million)
Table 43 RoW: Clinical Genomics Market Size, by Services, 2016-2023 (USD Million)
Table 44 RoW: Clinical Genomics Market Size, by Test Type, 2016-2023 (USD Million)
Table 45 RoW: Clinical Genomics Market Size, by Method, 2016-2023 (USD Million)
Table 46 RoW: Clinical Genomics Market Size, by End-User, 2016-2023 (USD Million)
Table 47 Recent Strategic Developments, by Company, 2014-2017
Table 48 Agreements, Collaborations, and Partnerships, 2014-2017
Table 49 New Product Launches & Enhancements, 2014-2017
Table 50 Expansions, 2014-2017
Table 51 Mergers & Acquisitions, 2014-2017
Table 52 Approvals, 2014-2017
Table 53 Other Developments, 2014-2017
List of Figures
Figure 1 Market Ecosystem
Figure 2 Key Stakeholders
Figure 3 Research Process
Figure 4 Key Executives Interviewed
Figure 5 Primary Research Techniques
Figure 6 Market Size Estimation
Figure 7 Meticulous Research Estimates: Diagnostic Testing Vs Prenatal Testing
Figure 8 Hospitals & Clinics End User Segment Is Expected to Dominate the Global Clinical Genomics Market During Forecast Period, 2018-2023
Figure 9 Where Are the Opportunities for You?
Figure 10 Key Adopters of Clinical Genomics Tests and Software Market
Figure 11 Market Share Analysis: Clinical Genomics Test/Software Industry, 2017
Figure 12 Market Dynamics
Figure 13 U.S. Molecular Diagnostic and Genetic Testing Spending, 2010-2021
Figure 14 U.S. DTC Genetic Test Volume, 2012-2016
Figure 15 Global Clinical Genomics Market Size, by Service, 2018-2023 (USD Million)
Figure 16 Global Clinical Genomics Market Size, by Test Type, 2018-2023 (USD Million)
Figure 17 Global Rapid Increase in Genetic Test Development for Diseases, 2013-2016
Figure 18 U.K. Clinical Genetic Testing Activities, 2010-2015
Figure 19 Number of Prenatal Down Syndrome Cases Diagnosed in Bosnia and Herzegovina, 2013-2015
Figure 20 Global Clinical Genomics Market Size, by Method, 2018-2023 (USD Million)
Figure 21 Global Clinical Genomics Market Size, by End-User, 2018-2023 (USD Million)
Figure 22 Funding for the Genome Research in the U.S., 2012-2016
Figure 23 Global Clinical Genomics Market Size, by Geography, 2018-2023 (USD Million)
Figure 24 Number of People Over 65 In the U.S., 2000-2050
Figure 25 Proportion of Canadians Aged 65 and Older with Major Chronic Diseases, 2014
Figure 26 Spending On R&D in Higher Education Sector, by Source of Funding and Scientific Field, 2014/2015
Figure 27 Spending On R&D in Higher Education Sector, by Source of Funding
Figure 28 Population Aged 65 and Over by Region: 2015 and 2050
Figure 29 Key Growth Strategies Adopted by Leading Players -2014-2017
Figure 30 Agreements, Collaboration, and Partnerships, by Company,2014-2017
Figure 31 New Product Launches & Enhancements, by Company, 2014-2017
Figure 32 Expansions, by Company, 2014-2017
Figure 33 Mergers & Acquisitions, by Company, 2014-2017
Figure 34 Approvals, by Company, 2014-2017
Figure 35 Other Development, by Company, 2014-2017
Figure 36 Quest Diagnostics Incorporated: Financial Overview-2014-2016
Figure 37 Eurofins Scientific SE: Financial Overview-2014-2016
Figure 38 Illumina, Inc.: Financial Overview-2014-2016
Figure 39 PerkinElmer, Inc.: Financial Overview-2014-2016
Figure 40 NeoGenomics Inc.: Financial Overview-2014-2016
Figure 41 Foundation Medicine, Inc.: Financial Overview-2014-2016
Figure 42 Rosetta Genomics Ltd.: Financial Overview-2014-2016
Figure 43 Invitae Corporation: Financial Overview-2014-2016
Figure 44 Myriad Genetics, Inc.: Financial Overview-2014-2016
Figure 45 Natera, Inc.: Financial Overview-2014-2016
Figure 46 Genomic Health, Inc.: Financial Overview-2014-2016
Figure 47 OPKO Health, Inc.: Financial Overview-2014-2016
We are in the phase of updating this report by analysing the impact of COVID-19 on this market.
We are in the phase of updating this report by analysing the impact of COVID-19 on this market.
Published Date: Mar-2023
